Skip to main content
CVE-2026-123050VulnerabilityPublished

Multiple Farmasimplex healthcare integration modules do not properly validate TLS certificates, allowing an attacker

Source GCVE Database

0
Compare
Authoritative record:CVE-2026-123050· High 7.1

Not known to be exploited · CVSS 7.1 High : upgrade to 16.2.0 soon.

Data as of 17 Nov 2026, 16:50 UTC

CVSS 4.0 base score
7.1High
How severe the flaw is on the 0–10 CVSS scale.

Thin evidence

One scorer or none
CVSS scores by source
CNA (ENISA)CVSS 4.07.1
Patch
Available – fixed in 16.2.0
CVSS:4.0/AV:N/AC:H/AT:N/PR:N/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N/E:U

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 17 Nov 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponized: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 16 Nov 2026.

What to do

Upgrade Farmasimplex to 16.2.0.

Affected software

ProductAffectedFixed in
CIPCarboneFarmasimplexAffected
  • <16.2.0
Fixed in
  • 16.2.0

AI-suggested

Until a fix is provided, organizations should consider mitigating risks by restricting network access to trusted endpoints and employing additional network-layer protections such as VPNs or secure tunnels to reduce interception risks.

Description

Multiple Farmasimplex healthcare integration modules fail to properly validate TLS certificates. This vulnerability allows attackers who can intercept network traffic to impersonate trusted healthcare services, enabling man-in-the-middle attacks that may disclose or modify sensitive data.

References

Community reviews

Loading reviews…